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ICPEMC is an international commission with sci-
entific expertise in the fields of environmental
mutagenesis, carcinogenesis andgenetic toxicology.
Its membership is recruited from universities, re-
search institutions, industry and national health au-
thorities. Its principal objective is to prevent and
minimize the deleterious effects resulting from the
interaction ofchemicals with the genetic material of
man. The Commission seeks toidentify and promote
scientific principles and to make recommendations
that may serve as the basis for guidelines and regu-
lations in the national or international context.
ICPEMC has two main strategies to achieve its ob-
jectives: The preparation of critical evaluations of
the current body of knowledge that may serve as a
basis for establishing priorities for further research
or possible regulatory action, and identification of
substances and situations that may entail significant
genotoxic damage to man.
TheCommission meets atregularintervals, forthe
timebeinginApril and September atVerte Rive near
Lausanne. The Executive Committee, consisting of
the ICPEMC officers (1) the president of IAEMS,
andtheVice-Chairman forliaisonwiththe Institutde
la Vie, exercises general oversight of ICPEMC and
itscommittee-activities and acts forthe Commission
between meetings.
In the first meetings, considerable attention was
given to defining the aims and objectives of the
Commission, in particular to the way the Commis-
sion should work. Agreement was reached that the
Commission should primarily function in a scientific
manner, as set out above, and refrain from making
statements carrying regulatory implications.
The organizational structure ofICPEMC has been
formalized in a constitution that, after intensive de-
bateinvariousmeetings, was adopted byunanimous
vote ofthe Commission in its fourth meeting in Sep-
tember 1978. The establishment of ICPEMC as a
nongovernmental organization will facilitate liaison
withorganizations that share its interest in resolving
problems posed by mutagens and carcinogens in the
human environment, such as UNEP, WHO, EEC,
and various otherinstitutions. In this context it may
be noted that ICPEMC is affiliated with the Interna-
tional Association of Environmental Mutagen
Societies and sponsored by the Institut de la Vie.
Task groups and committees have been estab-
lished by the Commission. Task groups are com-
posed mainly of Commission members, while the
membership ofcommittees consists mainly ofscien-
tists who are not members ofthe Commission. The
idea behind these ground rules is to achieve some
distribution oflabor. Moreover, to widen the avail-
able expertise, consultants can be appointed to
either body.
Task Group 1, consisting ofB. A. Bridges (chair-
man), N. P. Bochkov, H. B6hme, J. Clemmesen,
D. Jansen, T. Sugimura, and L. Tomatis, sets the
priorities for evaluating the genotoxic properties of
chemicals. These compounds are selected by Task
Group 1, aftercorrespondence andconsultationwith
Commission members. Human exposureconstitutes
an important criterion for selection and review by
ICPEMC. The procedure adopted so far has been
thatafirstdraftispreparedby one ormore Commis-
sionmembers. Thisworkingpaperiscirculated to all
members, amply discussed in ameeting ofthe Com-
mission, and subsequently revised. Small editorial
groups are constituted during the meeting. They are
composed ofdifferent members thanthose responsi-
bleforthe first draft, so as to achieve distribution of
work load and maximum objectivity. The first
document resulting from these activities is entitled
"Cigarette smoking -does itcarry agenetic risk?";
this paper has now been published (2) as ICPEMC
Publication No. 3. Other documents are being pre-
pared on isoniazide, epichlorohydrin, dichlorvos,
vinyl chloride, hair dyes, and psoriatics.
TaskGroup2, consisting ofB. Matter(chairman),
J. Drake, A. Hollaender, B. J. Kilbey, C. Ramel,
V. Ray, and K. Sundaram, hasprepared anadvisory
on the strategy for employing the best short-term
screening systems available at present. This report,
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Mutagenicity" has been published (3) as ICPEMC
Publication No. 2. ICPEMC encourages the use of
theavailable testsand urgesthataflexibleattitude be
adoptedwhenselectingtestsystems. Toincrease the
chances ofdetection, supplementation with metabo-
lizing extracts from mammalian tissues is recom-
mended. A combination of different assay systems
obviously augments the possibility that different
kinds ofgenetic damage are recovered. Reference is
made to the report of the European Environmental
Mutagen Society entitled "Mutagenicity Screening,
General Principles and Minimal Criteria" (4).
Task Group 3, consisting of B. A. Bridges (chair-
man), N. P. Bochkov, and J. D Jansen, prepared a
statement recommending genetic monitoring of
human populations accidentally exposed to a sus-
pected mutagenic chemical" which has appeared in
the literature (5-7). In brief, its contents are the fol-
lowing. When groups ofpeople are accidentally ex-
posed to high concentrations oftoxic chemicals, as
they were at Seveso in 1976, the health authorities'
first concern is quite rightly with acute toxicity and
possible teratogenic effects. However, when the
chemical is a mutagen, there will be questions con-
cerning damage to the victim's genetic material and
the possibility that genetic or carcinogenic effects
appear many years after the exposure. At present,
these questions cannot be satisfactorily answered,
because too little is known about chemical muta-
genesis in man. Obviously accidents are most re-
grettable, but it is reasoned that valuable scientific
information can be obtained by careful and syste-
matic studyoftheexposedgroupsandtheirprogeny.
Thus the following measures are recommended: (1)
rapid identification of the exposed population, and
quantitative estimates ofthe exposures suffered; (2)
assessment of possible mutagenic effects in the
somatic cells ofthe exposed individuals, employing
various detection techniques; (3) long-term moni-
toring of the accidentally exposed populations for
theincidence ofmalignancies, andtheiroffspringfor
genetic effects, such as spontaneous abortions and
congenital malformations. Knowledge thusobtained
will not only be ofbenefit forappropriately counsel-
ingthe exposed individual, but will also provide the
scientific basis required for evaluating future ex-
posures ofpopulations to mutagenic chemicals. The
magnitudeandassociatedcostsoftheeffortinvolved
and the unpredictability of when accidents may
occur, make early preparation for such studies and
their implementation an absolute necessity.
Task Group 4, consisting ofA. Hollaender (chair-
man), V. Ray, T. Sugimura, and L. Tomatis, is
engaged in formulating a statement on possible
tolerance limits or limits of exposure to mutagenic
chemicals at which no detrimental effect can be rec-
ognized.
Committee 1, chaired by B. J. Kilbey, is charged
with reviewing the development, validation, appli-
cation, and comparison of short-term screening
systems for identifying and characterizing chemical
mutagens. The first meeting took place at Versailles
from September 22 to September 25, 1978, and two
main areas were discussed: the criteria which the
tests should fulfill to be recommended by ICPEMC
and the work of the Committee during 1979. The
criteriafor suitable screening tests for mutagens can
be summarized as follows: (1) the damage scored in
the test should be damage believed to be of signifi-
canceto manhimself; (2)the testsystemshould have
the capacity for metabolizing the compound under
consideration, if possible in a way which reflects
metabolism in man. In addition the test should fulfill
the following operational standards: it should give
consistentresultswhenused indifferentlaboratories
and in repeats in the same laboratory; the results it
gives should be concordant with the other systems
used to screen for mutagenesis; the test should be
validated with respect to the response of whole
mammals as is done for carcinogenicity; the test
should be as sensitive as possible to the mutagenic
effects of nontoxic doses; the test should be cheap
andrapid. Aplanwasdeveloped tocollectthe above
information for a number of different test systems,
that have beenused with a great numberofdifferent
mutagenic chemicals. All compounds tested in the
whole mouse test will also be included since these
will form a useful starting point for validating the
screening tests.
Committee 2, chaired by D. B. Clayson, studies
the relationships between chemical carcinogens and
chemical mutagens. The Committee met at Ver-
salles, December4-6, 1978. Thefirsttwodays ofthe
meeting were occupied with the presentation of
working papers and verbal reports prepared by the
various Committee members. Working papers pre-
pared by D. B. Clayson, entitled "Differences be-
tweenin vivo andin vitro systems," by A. S. Wright,
entitled "Metabolic differencesin vivo andin vitro,"
andbyP. Brookeson "Celltransformation" are now
being circulated to Commission members, so that,
hopefully, in due time they can appear as ICPEMC
papers.
The aims ofCommittee 2 were redefined to sepa-
rate them more clearly from those ofCommittee 1.
Thesetasks arenowtoinvestigate: (1)towhatextent
aremutagenicity tests predictive ofcarcinogenicity?
(2) to what extent are transformation assays predic-
tiveofcarcinogenicity? (3) is there acausal relation-
ship between mutagenicity and carcinogenicity? (4)
is there a quantitative relationship between mutage-
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between in vitro transformation and mutagenicity?
Written reports bearing on these questions will be
prepared over the years 1979 and 1980, by the vari-
ous members of Committee 2.
Committee 3, chaired by E. Poulsen, is preparing
anongoing registry ofnational regulatory principles
and actions. The first meeting of Committee 3 took
place at Versailles, October 24-26, 1978. The task of
the Committee was discussed and interpreted. Data
sheets for the individual countries were developed.
TheywillbedividedintothoseforGroupIcountries,
consisting of EEC countries, Northern countries,
Austria, Switzerland, North America, COMECON
member states, and Japan, and those for Group II
countries, thatis, othercountries forwhich informa-
tion can be obtained. International guidelines and
proposals will be considered at the next meeting of
the Committee. P. Elias, will, in collaboration with
S. Igali, Y. Tazima, and C. J. Damme, develop the
four regional reports covering the Group I and II
countries by summer 1979, based on the guidelines
that were agreed upon in Versailles.
Committee 4, chaired by M. F. Lyon, is charged
with evaluation of risk estimate procedures of
mutagenic chemicals and the development ofpracti-
cal exposure limits. The first meeting of the Com-
mittee took place on July 12-13, 1978 in Dublin. The
Committee rearranged its task to comprise: (1)
dose-response relationships, covering: definition of
dose, dose-response curves, and pharmacokinetics;
(2) interaction of agents, mammalian systems; (3)
sensitivity ofgerm-cell stages; (4) spectraofinduced
genetic changes; (5) extrapolations from one species
to another and one cell type to another and struc-
ture-activity relationships from one chemical to
another; (6) genetically significant doses; (7) meth-
ods ofestimating resultant genetic damage. Reports
on these various topics will be prepared and consid-
ered at the next meeting.
Committee 5, to be chaired by J. R. Miller to
consideranepidemiological approachtothepossible
mutagenic consequences of exposure to environ-
mental agents, will start its activities in 1979.
In order to achieve maximum coordination and
interaction between the five ICPEMC Committees,
the Commission decided to organize a simultaneous
meeting ofall five committees in 1979. This meeting
is scheduled for September 17-20 at Chateau de
Ripaille in Thonon.
A request was received from the U.S. National
Academy of Sciences to provide the data available
on the mutagenic effects of saccharin. Following a
request by the secretary to all members both of the
Commission and the four committees of ICPEMC,
some20documents werereceivedandtransmitted to
the secretary of the National Academy. It is worth
noting that this is the first time that ICPEMC was
requested to provide information on the mutagenic
effects ofa special chemical by an "outside" institu-
tion. In this context it is also of interest to mention
thatthe National Swedish Environmental Protection
Board has asked ICPEMC to act in an advisory
capacity concerning an evaluation of the available
systems for mutagenicity testing which can serve as
a basis for decisions taken within government or-
ganizations and industry and to provide a system in
the field of evaluation of genetic hazards due to
chemical substances.
Informal liaison has been established with UNEP
andWHO, inthatobservers frombothorganizations
haveattended the second, third, andfourthCommis-
sion meetings in Lausanne. A request from WHO
wasreceived to send anobserverto ameetingon the
healtheffectsofsmoking. This wasarrangedthrough
the International Association of Environmental
Mutagen Societies.
ICPEMC received an invitation from UNEP to
send a representative to the 7th session ofthe Gov-
eming Council of the United Nations Environment
Program in Nairobi from April 18-May 4, 1979.
Contacts have also been established with the Inter-
national Commission on Radiation Protection
(ICRP) and the International Agency for Research
on Cancer (IARC). The Secretary received a large
number of requests for information and provided
relevant material concerning ICPEMC and its ac-
tivities. Financial support was received in 1978 also
fromtheCommissionofthe EuropeanCommunities,
Directorate-General for Research, Science and Edu-
cation.
ThehelpofProfessorMaurice Maroisand his staff
in organizing the meetings of the Commission and
committees in Lausanne and Versailles is gratefully
acknowledged.
REFERENCES
1. ICPEMC News No. 1, Mutat. Res. 54: 379 (1978).
2. Bridges, B. A., Clemmesen, J., and Sugimura, T. Cigarette
smoking.- does it carry a genetic risk? Mutat. Res. 65: 71
(1979).
3. ICPEMC Advice on screening ofchemicals formutagenicity.
Mutat. Res. 64: 155 (1979).
4. ReportofaCommittee oftheEuropeanEnvironmental Muta-
gen Society: mutagenicity screening, general principles and
minimalcriteria, Mutat. Res. 53: 361 (1978); Biol. Zbl. 97: 217
(1978).
5. Bridges, B. A., Bochkov, N. P., and Jansen, J. D. Genetic
monitoring of human populations accidentally exposed to a
suspected mutagenic chemical. Mutat. Res. 64: 57 (1979).
6. Bridges, B. A., Bochkov, N. P., Jansen, J. D. Genetic
monitoring of human populations accidentally exposed to a
suspected mutagenic chemical. Biol. Zbl. 98: 117 (1979).
7. Mutagens and man. Lancet, 8106: 59 (1979).
February 1980 225